UPDATE: Morgan Stanley Downgrades Alnylam Pharmaceuticals (ALNY) to Equalweight
Tweet Send to a Friend
(Updated - April 25, 2022 5:18 AM EDT)
Morgan Stanley analyst Matthew Harrison downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
